New Stock News | Syngenta Said to Restart Hong Kong Listing Process, Confidentially Files Application to Raise US$5 Billion
Syngenta Group, the agrochemical giant under Sinochem, has confidentially filed an initial public offering application with the Hong Kong Stock Exchange, according to people familiar with the matter. The company plans to raise approximately US$5 billion (about HK$39 billion) and aims to list next year.
According to people familiar with the matter, Syngenta Group, an agrochemical giant under Sinochem, has confidentially filed an initial public offering application with the Hong Kong Stock Exchange, planning to raise about US$5 billion (approximately HK$39 billion), and aims to list next year. If the process proceeds smoothly, it will be one of the largest IPO projects in the Hong Kong market in recent years.
This listing plan has been in the works for a long time. In April this year, reports mentioned that Syngenta planned to confidentially submit a Hong Kong listing application as early as June. In May, another report cited sources as saying that Syngenta planned to list on the Hong Kong Stock Exchange in September or October. If the confidential application is formally submitted, it means the process has entered a substantive stage.
Syngenta is headquartered in Switzerland and is a leading global company in the seeds and pesticides sector. It was acquired by ChemChina in 2017 for US$44 billion and is now part of Sinochem Holdings. The company operates in more than 90 countries worldwide and has over 50,000 employees.
Related Articles

Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice

Hebei Changshan Biochemical Pharmaceutical (300255.SZ): Heparin Sodium Injection obtains Moldova drug registration certificate.

Henan Mingtai Al.Industrial (601677.SH): Sale of 2.50% equity in Sanmenxia Aluminum terminated.
Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice

Hebei Changshan Biochemical Pharmaceutical (300255.SZ): Heparin Sodium Injection obtains Moldova drug registration certificate.

Henan Mingtai Al.Industrial (601677.SH): Sale of 2.50% equity in Sanmenxia Aluminum terminated.

RECOMMEND





